Market Cap (In USD)
336.24 Thousand
Revenue (In USD)
419.29 Thousand
Net Income (In USD)
-1.32 Million
Avg. Volume
674.36 Thousand
- Currency
- USD
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 0.0113-0.0547
- PE
- -
- EPS
- -
- Beta Value
- 0.397
- ISIN
- US1500431077
- CUSIP
- -
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Medical - Instruments & Supplies
- CEO
- Ms. Kate Monroe
- Employee Count
- -
- Website
- https://www.psykeyworld.com
- Ipo Date
- 2006-02-14
- Details
- Psykey, Inc. engages in the research, development, and commercialization of entheogenic, adaptogenic, and nootropic ingredients and formulations for its functional product lines to improve and optimize life. The company also engages in the development of technologies for the composition, bioavailability, and targeted delivery of entheogen-based therapeutics for the psychedelic market. Its retail products include functional mushroom coffees and teas, oral supplements, and single serve drink mixes. The company was formerly known as CeCors, Inc. and changed its name to Psykey, Inc. in August 2021. Psykey, Inc. was founded in 2002 and is based in Toronto, Canada.
More Stocks
-
UNIP3Unipar Carbocloro S.A.
UNIP3
-
BLPH
-
5134POPER Co.,Ltd.
5134
-
RIGS
-
5078CEL Corporation
5078
-
7500
-
3182Oisix ra daichi Inc.
3182
-
601929JiShi Media Co., Ltd.
601929